Description

The purpose of this session is to review the role of contrast enhanced ultrasound (CE US) in the abdomen. Despite the wide-spread use of CE US throughout the world, CE US was only approved this past spring by the FDA for the evaluation of liver masses in the United States. Hence, the practicalities of performing CE US will not be familiar to many practicing radiologists who wish to incorporate this significant advance in technology into their clinical practice. This session will highlight the logistics of how to introduce CE US in a clinical radiology practice outside of the research setting and will review the diagnostic criteria for interpreting CEUS evaluation of liver and renal masses. In addition, the course will review the role of CE US in evaluation of liver and renal masses in comparison to other imaging modalities such as CT and MR and the potential departmental financial impact of using CE US. Developed in conjunction with Society of Radiologists in Ultrasound.

Learning Objectives:

1. Discuss appropriate protocols for performance of contrast enhanced ultrasound examination of hepatic and renal masses.
2. Interpret contrast enhanced ultrasound examinations of hepatic and renal masses.
3. Describe the roles of contrast enhanced ultrasound, MR and CT in the evaluation of hepatic and renal masses.

Speaker(s):

• Leslie Scoutt, MD, FACR
• Edward Grant, MD, FACR
• Richard Barr, MD, Ph.D, FACR, FSRU
• Stephanie Wilson, MD
• Michelle Robbin, MD,MS, FACR, FSRU,FAIUM

Disclosures

• Leslie Scoutt, MD, FACR - Honorari - Phillips Healthcare

• Edward Grant, MD, FACR - Research Grants - GE Healthcare

• Richard Barr, MD, Ph.D, FACR, FSRU - This speaker has nothing to disclose

• Stephanie Wilson, MD - Consultant - Lantheus Medical Imaging, Inc

• Michelle Robbin, MD,MS, FACR, FSRU,FAIUM - Research Grants - Phillips Healthcare